250 related articles for article (PubMed ID: 9134635)
21. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
[TBL] [Abstract][Full Text] [Related]
22. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
23. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
Lazo G; Kantarjian H; Estey E; Thomas D; O'Brien S; Cortes J
Cancer; 2003 May; 97(9):2218-24. PubMed ID: 12712474
[TBL] [Abstract][Full Text] [Related]
24. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China.
Wang ZY; Sun GL; Lu JX; Gu LJ; Huang ME; Chen SR
Nouv Rev Fr Hematol (1978); 1990; 32(1):34-6. PubMed ID: 2349080
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of promyelocytic leukemia with retinoic acid: results in Cuba].
Hernández P; Carnot J; Dorticós E; Espinosa E; González A; Hernández G; Nordet I; Pérez A; Valdés C; Vergara B
Sangre (Barc); 1994 Oct; 39(5):357-63. PubMed ID: 7754440
[TBL] [Abstract][Full Text] [Related]
27. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.
Falanga A; Iacoviello L; Evangelista V; Belotti D; Consonni R; D'Orazio A; Robba L; Donati MB; Barbui T
Blood; 1995 Aug; 86(3):1072-81. PubMed ID: 7620161
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid syndrome in acute promyelocytic leukemia.
Sentero D; Hosenpud J
Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation.
Koçak U; Gürsel T; Oztürk G; Kantarci S
Pediatr Hematol Oncol; 2000 Mar; 17(2):177-80. PubMed ID: 10734661
[TBL] [Abstract][Full Text] [Related]
30. [Experience in administration low dose all-trans retinoic acid for a child with acute promyelocytic leukemia].
Hata M; Nakayama T; Hattori T; Okano S; Ito T; Abe T; Kamakura M; Iinuma H; Okinaga K; Yasuda K
Rinsho Ketsueki; 1996 Feb; 37(2):129-33. PubMed ID: 8852030
[TBL] [Abstract][Full Text] [Related]
31. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute promyelocytic leukemia: a single institution experience.
Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
[TBL] [Abstract][Full Text] [Related]
34. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract][Full Text] [Related]
35. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
Soma M; Maeda Y; Kasakura S; Yabe H
Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
[TBL] [Abstract][Full Text] [Related]
36. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
[TBL] [Abstract][Full Text] [Related]
37. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
38. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
Kuo MC; Dunn P; Wu JH; Shih LY
Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
[TBL] [Abstract][Full Text] [Related]
39. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
Fujita H; Nakaya A; Kato J; Tachibana T; Takemura S; Hyo R; Kawano T; Tanaka M; Taguchi J; Maruta A; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1095-9. PubMed ID: 16440769
[TBL] [Abstract][Full Text] [Related]
40. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
